Report cover image

Neonatal Intensive Care Respiratory Devices

Publisher Cognitive Market Research
Published Mar 01, 2026
SKU # COG21170332

Description

According to Cognitive Market Research, the global neonatal intensive care respiratory devices market size will be USD 1862.8 million in 2025. It will enlarge at a compound annual growth rate (CAGR) of 6.2% from 2025 to 2033.

North America held the major market share for more than 37% of the global revenue with a market size of USD 689.2 million in 2025 and will prosper at a compound annual growth rate (CAGR) of 4.7% from 2025 to 2033.

Europe accounted for the second largest market share of over 29% of the global revenue, with a market size of USD 540.2 million.

APAC held a market share of around 24% of the global revenue with a market size of USD 447.1 million in 2025 and will flourish at a compound annual growth rate (CAGR) of 8.9% from 2025 to 2033.

South America has a market share of more than 4% of the global revenue with a market size of USD 70.8 million in 2025 and will thrive at a compound annual growth rate (CAGR) of 6.9% from 2025 to 2033.

Middle East had a market share of around 4% of the global revenue and was estimated at a market size of USD 74.5 million in 2025 and will heighten at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2033.

Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 41 million in 2025 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2033.

The CPAP device type is the fastest-growing category of the neonatal intensive care respiratory devices industry.

Table of Contents

Chapter 1 2026 Geopolitical Outlook - Neonatal Intensive Care Respiratory Devices Market Detailed Analysis
Chapter 2 AI's Impact on Market - Detailed Qualitative Analysis
Chapter 3 Global Market Analysis
3.1 Global Neonatal Intensive Care Respiratory Devices Revenue Market Size, Trend Analysis 2022 - 2034
3.2 Global Neonatal Intensive Care Respiratory Devices Market Size By Regions 2022 - 2034
3.2.1 Global Neonatal Intensive Care Respiratory Devices Revenue Market Size By Region
3.3 Global Neonatal Intensive Care Respiratory Devices Market Size By Device Type Outlook: 2022 - 2034
3.3.1 Nebulizers Market Size
3.3.2 Inhalers Market Size
3.3.3 Ventilators Market Size
3.3.4 CPAP Devices Market Size
3.3.5 Apnea Monitors Market Size
3.3.6 Others Market Size
3.4 Global Neonatal Intensive Care Respiratory Devices Market Size By End-User Outlook: 2022 - 2034
3.4.1 NICU Hospitals Market Size
3.4.2 Specialty Clinics Market Size
3.4.3 Nursing Homes Market Size
3.5 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
3.6 Executive Summary Global Market (2021 vs 2025 vs 2033)
3.6.1 Regional Market Revenue Summary 2021 vs 2025 vs 2033
3.6.2 Global Market Revenue Split By Device Type Outlook:
3.6.3 Global Market Revenue Split By End-User Outlook:
3.6.4 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Chapter 4 North America Market Analysis
4.1 North America Neonatal Intensive Care Respiratory Devices Market Outlook
4.1.1 North America Neonatal Intensive Care Respiratory Devices Market Size 2022 - 2034
4.1.2 North America Neonatal Intensive Care Respiratory Devices Market Size By Country 2022 - 2034
4.1.3 North America Neonatal Intensive Care Respiratory Devices Market Size by Device Type Outlook: 2022 - 2034
4.1.3.1 North America Nebulizers Market Size
4.1.3.2 North America Inhalers Market Size
4.1.3.3 North America Ventilators Market Size
4.1.3.4 North America CPAP Devices Market Size
4.1.3.5 North America Apnea Monitors Market Size
4.1.3.6 North America Others Market Size
4.1.4 North America Neonatal Intensive Care Respiratory Devices Market Size by End-User Outlook: 2022 - 2034
4.1.4.1 North America NICU Hospitals Market Size
4.1.4.2 North America Specialty Clinics Market Size
4.1.4.3 North America Nursing Homes Market Size
Chapter 5 Europe Market Analysis
5.1 Europe Neonatal Intensive Care Respiratory Devices Market Outlook
5.1.1 Europe Neonatal Intensive Care Respiratory Devices Market Size 2022 - 2034
5.1.2 Europe Neonatal Intensive Care Respiratory Devices Market Size By Country 2022 - 2034
5.1.3 Europe Neonatal Intensive Care Respiratory Devices Market Size by Device Type Outlook: 2022 - 2034
5.1.3.1 Europe Nebulizers Market Size
5.1.3.2 Europe Inhalers Market Size
5.1.3.3 Europe Ventilators Market Size
5.1.3.4 Europe CPAP Devices Market Size
5.1.3.5 Europe Apnea Monitors Market Size
5.1.3.6 Europe Others Market Size
5.1.4 Europe Neonatal Intensive Care Respiratory Devices Market Size by End-User Outlook: 2022 - 2034
5.1.4.1 Europe NICU Hospitals Market Size
5.1.4.2 Europe Specialty Clinics Market Size
5.1.4.3 Europe Nursing Homes Market Size
Chapter 6 Asia Pacific Market Analysis
6.1 Asia Pacific Neonatal Intensive Care Respiratory Devices Market Outlook
6.1.1 Asia Pacific Neonatal Intensive Care Respiratory Devices Market Size 2022 - 2034
6.1.2 Asia Pacific Neonatal Intensive Care Respiratory Devices Market Size By Country 2022 - 2034
6.1.3 Asia Pacific Neonatal Intensive Care Respiratory Devices Market Size by Device Type Outlook: 2022 - 2034
6.1.3.1 Asia Pacific Nebulizers Market Size
6.1.3.2 Asia Pacific Inhalers Market Size
6.1.3.3 Asia Pacific Ventilators Market Size
6.1.3.4 Asia Pacific CPAP Devices Market Size
6.1.3.5 Asia Pacific Apnea Monitors Market Size
6.1.3.6 Asia Pacific Others Market Size
6.1.4 Asia Pacific Neonatal Intensive Care Respiratory Devices Market Size by End-User Outlook: 2022 - 2034
6.1.4.1 Asia Pacific NICU Hospitals Market Size
6.1.4.2 Asia Pacific Specialty Clinics Market Size
6.1.4.3 Asia Pacific Nursing Homes Market Size
Chapter 7 South America Market Analysis
7.1 South America Neonatal Intensive Care Respiratory Devices Market Outlook
7.1.1 South America Neonatal Intensive Care Respiratory Devices Market Size 2022 - 2034
7.1.2 South America Neonatal Intensive Care Respiratory Devices Market Size By Country 2022 - 2034
7.1.3 South America Neonatal Intensive Care Respiratory Devices Market Size by Device Type Outlook: 2022 - 2034
7.1.3.1 South America Nebulizers Market Size
7.1.3.2 South America Inhalers Market Size
7.1.3.3 South America Ventilators Market Size
7.1.3.4 South America CPAP Devices Market Size
7.1.3.5 South America Apnea Monitors Market Size
7.1.3.6 South America Others Market Size
7.1.4 South America Neonatal Intensive Care Respiratory Devices Market Size by End-User Outlook: 2022 - 2034
7.1.4.1 South America NICU Hospitals Market Size
7.1.4.2 South America Specialty Clinics Market Size
7.1.4.3 South America Nursing Homes Market Size
Chapter 8 Middle East Market Analysis
8.1 Middle East Neonatal Intensive Care Respiratory Devices Market Outlook
8.1.1 Middle East Neonatal Intensive Care Respiratory Devices Market Size 2022 - 2034
8.1.2 Middle East Neonatal Intensive Care Respiratory Devices Market Size By Country 2022 - 2034
8.1.3 Middle East Neonatal Intensive Care Respiratory Devices Market Size by Device Type Outlook: 2022 - 2034
8.1.3.1 Middle East Nebulizers Market Size
8.1.3.2 Middle East Inhalers Market Size
8.1.3.3 Middle East Ventilators Market Size
8.1.3.4 Middle East CPAP Devices Market Size
8.1.3.5 Middle East Apnea Monitors Market Size
8.1.3.6 Middle East Others Market Size
8.1.4 Middle East Neonatal Intensive Care Respiratory Devices Market Size by End-User Outlook: 2022 - 2034
8.1.4.1 Middle East NICU Hospitals Market Size
8.1.4.2 Middle East Specialty Clinics Market Size
8.1.4.3 Middle East Nursing Homes Market Size
Chapter 9 Africa Market Analysis
9.1 Africa Neonatal Intensive Care Respiratory Devices Market Outlook
9.1.1 Africa Neonatal Intensive Care Respiratory Devices Market Size 2022 - 2034
9.1.2 Africa Neonatal Intensive Care Respiratory Devices Market Size By Country 2022 - 2034
9.1.3 Africa Neonatal Intensive Care Respiratory Devices Market Size by Device Type Outlook: 2022 - 2034
9.1.3.1 Africa Nebulizers Market Size
9.1.3.2 Africa Inhalers Market Size
9.1.3.3 Africa Ventilators Market Size
9.1.3.4 Africa CPAP Devices Market Size
9.1.3.5 Africa Apnea Monitors Market Size
9.1.3.6 Africa Others Market Size
9.1.4 Africa Neonatal Intensive Care Respiratory Devices Market Size by End-User Outlook: 2022 - 2034
9.1.4.1 Africa NICU Hospitals Market Size
9.1.4.2 Africa Specialty Clinics Market Size
9.1.4.3 Africa Nursing Homes Market Size
Chapter 10 Competitor Analysis (Subject to Data Availability (Private Players))
10.1 Top Competitors Analysis
10.1.1 Global Neonatal Intensive Care Respiratory Devices Market Revenue and Share by Key Players
10.1.2 Top Players Ranking 2024
10.1.3 New Product Launch Analysis
10.1.4 Industry Mergers and Acquisition Analysis
10.2 Company Profile (Data Subject to Availability) Sample Format
10.2.1 Philips Healthcare (Netherlands)
10.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.1.2 Business Overview
10.2.1.3 Financials (Subject to data availability)
10.2.1.4 R&D Investment (Subject to data availability)
10.2.1.5 Product Types Specification
10.2.1.6 Business Strategy
10.2.1.7 Recent Developments
10.2.1.8 Management Change
10.2.1.9 S.W.O.T Analysis
10.2.2 GE Healthcare (U.S.)
10.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.2.2 Business Overview
10.2.2.3 Financials (Subject to data availability)
10.2.2.4 R&D Investment (Subject to data availability)
10.2.2.5 Product Types Specification
10.2.2.6 Business Strategy
10.2.2.7 Recent Developments
10.2.2.8 Management Change
10.2.2.9 S.W.O.T Analysis
10.2.3 Medtronic (Ireland)
10.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.3.2 Business Overview
10.2.3.3 Financials (Subject to data availability)
10.2.3.4 R&D Investment (Subject to data availability)
10.2.3.5 Product Types Specification
10.2.3.6 Business Strategy
10.2.3.7 Recent Developments
10.2.3.8 Management Change
10.2.3.9 S.W.O.T Analysis
10.2.4 Drägerwerk AG & Co. KGaA (Germany)
10.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.4.2 Business Overview
10.2.4.3 Financials (Subject to data availability)
10.2.4.4 R&D Investment (Subject to data availability)
10.2.4.5 Product Types Specification
10.2.4.6 Business Strategy
10.2.4.7 Recent Developments
10.2.4.8 Management Change
10.2.4.9 S.W.O.T Analysis
10.2.5 Hamilton Medical (Switzerland)
10.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.5.2 Business Overview
10.2.5.3 Financials (Subject to data availability)
10.2.5.4 R&D Investment (Subject to data availability)
10.2.5.5 Product Types Specification
10.2.5.6 Business Strategy
10.2.5.7 Recent Developments
10.2.5.8 Management Change
10.2.5.9 S.W.O.T Analysis
10.2.6 Nihon Kohden Corporation (Japan)
10.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.6.2 Business Overview
10.2.6.3 Financials (Subject to data availability)
10.2.6.4 R&D Investment (Subject to data availability)
10.2.6.5 Product Types Specification
10.2.6.6 Business Strategy
10.2.6.7 Recent Developments
10.2.6.8 Management Change
10.2.6.9 S.W.O.T Analysis
10.2.7 ResMed (U.S.)
10.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.7.2 Business Overview
10.2.7.3 Financials (Subject to data availability)
10.2.7.4 R&D Investment (Subject to data availability)
10.2.7.5 Product Types Specification
10.2.7.6 Business Strategy
10.2.7.7 Recent Developments
10.2.7.8 Management Change
10.2.7.9 S.W.O.T Analysis
10.2.8 Smiths Group Plc (U.S.)
10.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.8.2 Business Overview
10.2.8.3 Financials (Subject to data availability)
10.2.8.4 R&D Investment (Subject to data availability)
10.2.8.5 Product Types Specification
10.2.8.6 Business Strategy
10.2.8.7 Recent Developments
10.2.8.8 Management Change
10.2.8.9 S.W.O.T Analysis
10.2.9 Vyaire Medical (U.S.)
10.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.9.2 Business Overview
10.2.9.3 Financials (Subject to data availability)
10.2.9.4 R&D Investment (Subject to data availability)
10.2.9.5 Product Types Specification
10.2.9.6 Business Strategy
10.2.9.7 Recent Developments
10.2.9.8 Management Change
10.2.9.9 S.W.O.T Analysis
10.2.10 Becton
10.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.10.2 Business Overview
10.2.10.3 Financials (Subject to data availability)
10.2.10.4 R&D Investment (Subject to data availability)
10.2.10.5 Product Types Specification
10.2.10.6 Business Strategy
10.2.10.7 Recent Developments
10.2.10.8 Management Change
10.2.10.9 S.W.O.T Analysis
10.2.11 Dickinson & Company (U.S.)
10.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.11.2 Business Overview
10.2.11.3 Financials (Subject to data availability)
10.2.11.4 R&D Investment (Subject to data availability)
10.2.11.5 Product Types Specification
10.2.11.6 Business Strategy
10.2.11.7 Recent Developments
10.2.11.8 Management Change
10.2.11.9 S.W.O.T Analysis
10.2.12 Fisher & Paykel Healthcare (New Zealand)
10.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.12.2 Business Overview
10.2.12.3 Financials (Subject to data availability)
10.2.12.4 R&D Investment (Subject to data availability)
10.2.12.5 Product Types Specification
10.2.12.6 Business Strategy
10.2.12.7 Recent Developments
10.2.12.8 Management Change
10.2.12.9 S.W.O.T Analysis
10.2.13 Getinge AB (Sweden)
10.2.13.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.13.2 Business Overview
10.2.13.3 Financials (Subject to data availability)
10.2.13.4 R&D Investment (Subject to data availability)
10.2.13.5 Product Types Specification
10.2.13.6 Business Strategy
10.2.13.7 Recent Developments
10.2.13.8 Management Change
10.2.13.9 S.W.O.T Analysis
10.2.14 Inspiration Healthcare Group plc (U.K.)
10.2.14.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.14.2 Business Overview
10.2.14.3 Financials (Subject to data availability)
10.2.14.4 R&D Investment (Subject to data availability)
10.2.14.5 Product Types Specification
10.2.14.6 Business Strategy
10.2.14.7 Recent Developments
10.2.14.8 Management Change
10.2.14.9 S.W.O.T Analysis
10.2.15 Allied Healthcare Products Inc. (U.S.)
10.2.15.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.15.2 Business Overview
10.2.15.3 Financials (Subject to data availability)
10.2.15.4 R&D Investment (Subject to data availability)
10.2.15.5 Product Types Specification
10.2.15.6 Business Strategy
10.2.15.7 Recent Developments
10.2.15.8 Management Change
10.2.15.9 S.W.O.T Analysis
10.2.16 Acutronic Medical Systems AG (Switzerland)
10.2.16.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
10.2.16.2 Business Overview
10.2.16.3 Financials (Subject to data availability)
10.2.16.4 R&D Investment (Subject to data availability)
10.2.16.5 Product Types Specification
10.2.16.6 Business Strategy
10.2.16.7 Recent Developments
10.2.16.8 Management Change
10.2.16.9 S.W.O.T Analysis
Chapter 11 Qualitative Analysis (Subject to Data Availability)
11.1 Market Drivers
11.2 Market Restraints
11.3 Market Trends
11.4 Market Opportunity
11.5 Technological Road Map (Subject to Data Availability)
11.6 Product Life Cycle (Subject to Data Availability)
11.7 Consumer Preference Analysis
11.8 Market Attractiveness Analysis
11.9 PESTEL Analysis
11.9.1 Political Factors
11.9.2 Economic Factors
11.9.3 Social Factors
11.9.4 Technological Factors
11.9.5 Legal Factors
11.9.6 Environmental Factors
11.10 Industrial Chain Analysis (Subject to Data Availability)
11.10.1 Industry Chain Analysis
11.10.2 Manufacturing Cost Analysis
11.10.3 Supply Side Analysis
11.10.3.1 Raw Material Analysis
11.10.3.2 Raw Material Procurement Analysis
11.10.3.3 Raw Material Price Trend Analysis
11.11 Porter’s Five Forces Analysis
11.11.1 Bargaining Power of Suppliers
11.11.2 Bargaining Power of Buyers
11.11.3 Threat of New Entrants
11.11.4 Threat of Substitutes
11.11.5 Degree of Competition
11.12 Patent Analysis (Subject to Data Availability)
11.13 ESG Analysis
Chapter 12 Market Split by Device Type Outlook: Analysis 2022 - 2034
12.1 Nebulizers
12.1.1 Global Neonatal Intensive Care Respiratory Devices Revenue Market Size and Share by Nebulizers 2022 - 2034
12.2 Inhalers
12.2.1 Global Neonatal Intensive Care Respiratory Devices Revenue Market Size and Share by Inhalers 2022 - 2034
12.3 Ventilators
12.3.1 Global Neonatal Intensive Care Respiratory Devices Revenue Market Size and Share by Ventilators 2022 - 2034
12.4 CPAP Devices
12.4.1 Global Neonatal Intensive Care Respiratory Devices Revenue Market Size and Share by CPAP Devices 2022 - 2034
12.5 Apnea Monitors
12.5.1 Global Neonatal Intensive Care Respiratory Devices Revenue Market Size and Share by Apnea Monitors 2022 - 2034
12.6 Others
12.6.1 Global Neonatal Intensive Care Respiratory Devices Revenue Market Size and Share by Others 2022 - 2034
Chapter 13 Market Split by End-User Outlook: Analysis 2022 - 2034
13.1 NICU Hospitals
13.1.1 Global Neonatal Intensive Care Respiratory Devices Revenue Market Size and Share by NICU Hospitals 2022 - 2034
13.2 Specialty Clinics
13.2.1 Global Neonatal Intensive Care Respiratory Devices Revenue Market Size and Share by Specialty Clinics 2022 - 2034
13.3 Nursing Homes
13.3.1 Global Neonatal Intensive Care Respiratory Devices Revenue Market Size and Share by Nursing Homes 2022 - 2034
Chapter 14 Research Findings
14.1 Key Takeaways
14.2 Analyst Point of View
14.3 Assumptions and Acronyms
Chapter 15 Research Methodology and Sources
15.1 Primary Data Collection
15.1.1 Steps for Primary Data Collection
15.1.1.1 Identification of KOL
15.1.2 Backward Integration
15.1.3 Forward Integration
15.1.4 How Primary Research Help Us
15.1.5 Modes of Primary Research
15.2 Secondary Research
15.2.1 How Secondary Research Help Us
15.2.2 Sources of Secondary Research
15.3 Data Validation
15.3.1 Data Triangulation
15.3.2 Top Down & Bottom Up Approach
15.3.3 Cross check KOL Responses with Secondary Data
15.4 Data Representation

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us